Nivolumab is a monoclonal antibody that works by binding to a protein called PD-1 on a type of immune cell called T-cell. Read More
NHS becomes first health service in Europe to offer new cancer jab … from the Independent Jane Kirby

Nivolumab is a monoclonal antibody that works by binding to a protein called PD-1 on a type of immune cell called T-cell. Read More